UK Unveils $523M Investment in 100,000 Genomes Project; Illumina is Key Partner | GenomeWeb

NEW YORK (GenomeWeb News) – UK Prime Minster David Cameron today unveiled a £311 million ($523 million) investment package that includes a partnership between Genomics England and Illumina and will fund its national genome sequencing initiative, the 100,000 Genomes Project.

The UK created Genomics England as a company wholly owned by the Department of Health to oversee its effort to sequence and analyze the genomes of 100,000 people, a project that aims to advance the larger goal of integrating genomic medicine into the National Health Service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions. 

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies. 

Mar
17
Sponsored by
Qiagen

This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.